Dr. Omar R. Kayaleh, MD

Dr. Kayaleh practices at Arnold Palmer Hospital for Children in Orlando, Florida.

Dr. Kayaleh's NPI, 1407830193, was assigned on December 6, 2005. Dr. Kayaleh graduated from University Of Florida College Of Medicine in 1985. Dr. Kayaleh holds Florida license ME53036.

Dr. Kayaleh's primary practice is Arnold Palmer Hospital for Children, at 92 W Miller St, Orlando, FL 32806 in Orange County. The practice phone is (407) 650-5028.

Dr. Kayaleh's primary practice is Arnold Palmer Hospital for Children in Orlando, Florida. Dr. Kayaleh is also affiliated with Orlando Regional Medical Center. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Kayaleh to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kayaleh practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kayaleh's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kayaleh is board certified in hematology by the American Board of Internal Medicine. Dr. Kayaleh is licensed in Florida.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and prostate cancer among the conditions Dr. Kayaleh treats.

CMS data shows 801 Medicare services from Dr. Kayaleh across 6 procedure codes in 2024, for 268 Medicare patients. Medicare paid $66,773 for them.

CMS counts 268 Medicare patients who saw Dr. Kayaleh in 2024. The largest group is 65 to 74, with 123 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kayaleh's median patient age at 72, with 48% women.

In 2024, Dr. Kayaleh wrote 1,122 Medicare Part D claims for 207 patients. 78% of them were for generic drugs. CMS names the drug for 891 of them, across 25 drugs with 11 or more claims each, at $2,352,365 in total drug cost. In 2023, CMS named 742 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Kayaleh for performance year 2024, reported as part of a group. Dr. Kayaleh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kayaleh as offering telehealth.

Dmand AI links 6 papers to Dr. Kayaleh, published from 2014 to 2024. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Kayaleh's most frequent co-authors are Daniel J. Buchholz, MD, Sarah R. Cheyney, MD, MPH and Elizabeth C. Dees, MD.

Dmand AI links Dr. Kayaleh to 5 clinical trials, 3 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Rectal Diseases, Colonic Neoplasms and Esophageal Squamous Cell Carcinoma. Alliance for Clinical Trials in Oncology sponsors the most, 2.

CMS Open Payments shows 11 general payments to Dr. Kayaleh from 10 drug and device companies from 2017 to 2024. Consulting fees make up the largest share, 82% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,337.

Dr. Kayaleh graduated from University Of Florida College Of Medicine in 1985.

Dr. Kayaleh is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.